Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant
- PMID: 1310559
- DOI: 10.1016/0042-6822(92)90326-k
Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant
Abstract
Herpes simplex virus type 1 (HSV-1) mutant viruses lacking functional viral thymidine kinase activity are reported to be incapable of replication in neurons. To investigate the role of viral thymidine kinase (TK) activity in the HSV-1 infection of the neuron, we studied a thymidine kinase-negative (TK-) mutant virus engineered to eliminate TK function without affecting the other known transcripts encoded in this region of the genome. Studies using the mouse eye model demonstrated that the mutant behaved as is reported for other TK- viruses: DNA of the mutant virus was detected in the ganglia during the latent infection by polymerase chain reaction, but virus did not reactivate after explantation of the ganglia. Utilizing the neuronal cultures, we investigated the ability of the mutant virus to replicate in neurons and the capacity of the mutant virus to establish latency and reactivate. With a low multiplicity of infection (m.o.i.), replication of the TK- mutant virus in sensory neurons in culture was significantly delayed compared to that of the wild-type virus. However, when a high m.o.i. was used, the mutant and the wild-type viruses replicated with similar kinetics. The TK- mutant virus was capable of establishment of latency and reactivation from the latent infection in sensory neurons in culture. These data suggest that HSV-1 thymidine kinase activity facilitates viral replication, but that TK activity is not essential for either replication or reactivation from latent infections in neurons in vitro.
Similar articles
-
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.Proc Natl Acad Sci U S A. 1989 Jun;86(12):4736-40. doi: 10.1073/pnas.86.12.4736. Proc Natl Acad Sci U S A. 1989. PMID: 2543985 Free PMC article.
-
Neuronal control of herpes simplex virus latency.Virology. 1993 Aug;195(2):337-47. doi: 10.1006/viro.1993.1384. Virology. 1993. PMID: 8393231
-
Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.J Virol. 2017 Jan 31;91(4):e01979-16. doi: 10.1128/JVI.01979-16. Print 2017 Feb 15. J Virol. 2017. PMID: 27974554 Free PMC article.
-
Role of herpes simplex virus thymidine kinase expression in viral pathogenesis and latency.Intervirology. 1991;32(2):76-92. doi: 10.1159/000150188. Intervirology. 1991. PMID: 1851146 Review.
-
Biological and molecular aspects on herpes simplex virus latency.Scand J Infect Dis Suppl. 1990;69:113-9. Scand J Infect Dis Suppl. 1990. PMID: 2175937 Review.
Cited by
-
Infection of human NT2 cells and differentiated NT-neurons with herpes simplex virus and replication-incompetent herpes simplex virus vectors.J Neurovirol. 2001 Feb;7(1):43-51. doi: 10.1080/135502801300069656. J Neurovirol. 2001. PMID: 11519481
-
Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways.J Virol. 1996 Aug;70(8):5476-86. doi: 10.1128/JVI.70.8.5476-5486.1996. J Virol. 1996. PMID: 8764059 Free PMC article.
-
Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.J Virol. 1996 Feb;70(2):1271-6. doi: 10.1128/JVI.70.2.1271-1276.1996. J Virol. 1996. PMID: 8551594 Free PMC article.
-
Progress and problems with the use of suicide genes for targeted cancer therapy.Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):113-128. doi: 10.1016/j.addr.2015.05.009. Epub 2015 May 22. Adv Drug Deliv Rev. 2016. PMID: 26004498 Free PMC article. Review.
-
Herpes Simplex Virus 1 Replication, Ocular Disease, and Reactivations from Latency Are Restricted Unilaterally after Inoculation of Virus into the Lip.J Virol. 2019 Nov 26;93(24):e01586-19. doi: 10.1128/JVI.01586-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31554680 Free PMC article.